BioCentury
ARTICLE | Clinical News

Ingenex regulatory update

July 25, 1994 7:00 AM UTC

Ingenex Inc. Ingenex, a subsidiary of Titan Pharmaceuticals Inc. received notice of allowance for a U.S. patent covering Ingenex's IGX monoclonal antibody for reversing multi-drug resistance (MDR). ...